CA2656485A1 - Method, composition and device for sampling natriuretic peptides in a biological fluid - Google Patents

Method, composition and device for sampling natriuretic peptides in a biological fluid Download PDF

Info

Publication number
CA2656485A1
CA2656485A1 CA002656485A CA2656485A CA2656485A1 CA 2656485 A1 CA2656485 A1 CA 2656485A1 CA 002656485 A CA002656485 A CA 002656485A CA 2656485 A CA2656485 A CA 2656485A CA 2656485 A1 CA2656485 A1 CA 2656485A1
Authority
CA
Canada
Prior art keywords
protease inhibitor
bnp
fluid
biological fluid
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002656485A
Other languages
English (en)
French (fr)
Inventor
Ute Schellenberger
Eric E. Niederkofler
Urban A. Kiernan
Jessica O'rear
Randall W. Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crimson International Assets LLC
Original Assignee
Scios LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios LLC filed Critical Scios LLC
Publication of CA2656485A1 publication Critical patent/CA2656485A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
CA002656485A 2008-02-27 2009-02-27 Method, composition and device for sampling natriuretic peptides in a biological fluid Abandoned CA2656485A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/038,355 US9482677B2 (en) 2008-02-27 2008-02-27 Method, composition and device for sampling natriuretic peptides in a biological fluid
US12/038,355 2008-02-27

Publications (1)

Publication Number Publication Date
CA2656485A1 true CA2656485A1 (en) 2009-08-27

Family

ID=40671134

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002656485A Abandoned CA2656485A1 (en) 2008-02-27 2009-02-27 Method, composition and device for sampling natriuretic peptides in a biological fluid

Country Status (4)

Country Link
US (3) US9482677B2 (enExample)
EP (1) EP2098866B1 (enExample)
JP (1) JP5734547B2 (enExample)
CA (1) CA2656485A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
NO2491401T3 (enExample) * 2009-10-21 2018-11-03
BR112014003787A2 (pt) * 2011-08-23 2020-10-27 Synapse B.V. inibidores termoestáveis de ativação do sistema de coagulação sanguínea por contato com superfícies estranhas
EP2757151B1 (en) * 2011-09-13 2017-08-30 Olympus Corporation Method for inhibiting protease in biological sample containing pancreatic juice component
EP2866029B1 (en) 2012-06-22 2017-05-03 Olympus Corporation Method for preparing sample containing pancreatic juice component, and kit for storing biological sample containing pancreatic juice component at room temperature
EP2972391A1 (en) * 2013-03-15 2016-01-20 Molecular BioProducts, Inc. Methods to assess enzyme activity using mass spectrometric immunoassay
JP6907188B2 (ja) 2015-08-13 2021-07-21 ダイアックス コーポレーション 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092465A (en) 1960-03-25 1963-06-04 Miles Lab Diagnostic test device for blood sugar
DE1598153C3 (de) 1966-11-22 1973-11-22 Boehringer Mannheim Gmbh, 6800 Mannheim Diagnostisches Mittel zum Nach weis der Inhaltsstoffe von Korperflus sigkeiten
US3783672A (en) * 1972-02-23 1974-01-08 A Morgolenko High-speed machines for shaping metals which employ the energy of high-pressure gas
DE3029579C2 (de) 1980-08-05 1985-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut
US4816224A (en) 1980-08-05 1989-03-28 Boehringer Mannheim Gmbh Device for separating plasma or serum from whole blood and analyzing the same
US5135719A (en) 1986-10-29 1992-08-04 Biotrack, Inc. Blood separation device comprising a filter and a capillary flow pathway exiting the filter
US4820737A (en) 1987-02-17 1989-04-11 University Of Iowa Research Foundation Lacrimal secretion stimulant (lss)
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
WO1996037777A1 (en) * 1995-05-23 1996-11-28 Nelson Randall W Mass spectrometric immunoassay
PT914344E (pt) * 1996-03-04 2005-10-31 Scios Inc Ensaio e reagentes para a quantificacao de hbnp
DE19628236A1 (de) 1996-07-12 1998-01-15 Boehringer Mannheim Gmbh Reagenz zur Erhöhung der Serinproteasen-Inhibitionsspezifität
US6102872A (en) * 1997-11-03 2000-08-15 Pacific Biometrics, Inc. Glucose detector and method
CA2321560C (en) 1998-03-13 2007-05-22 Johns Hopkins University School Of Medicine The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
US6806075B1 (en) * 1998-06-05 2004-10-19 Schering Ag Corin, a serine protease
GB9827348D0 (en) 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
US6407211B1 (en) 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
CA2434699A1 (en) 2001-01-17 2002-10-17 Randall W. Nelson An integrated high throughput system for the analysis of biomolecules
WO2003097237A2 (en) 2002-05-13 2003-11-27 Becton, Dickinson, And Company Protease inhibitor sample collection system
CA2430889A1 (en) 2002-06-19 2003-12-19 Bayer Corporation Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
US7341838B2 (en) * 2003-04-17 2008-03-11 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
ATE517124T1 (de) 2003-05-12 2011-08-15 Hoffmann La Roche Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 42- 46 bindet
US7083163B2 (en) * 2003-09-19 2006-08-01 Tenneco Automotive Operating Company Inc. Booster with spring to adapt air spring pressure for load dependent shock absorber
DE10355731A1 (de) * 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP
US20060183681A1 (en) * 2005-02-14 2006-08-17 Bio-Rad Laboratories, Inc. Stabilized compositions containing natriuretic peptides
WO2007041645A2 (en) 2005-10-03 2007-04-12 Scios Inc. Oxidized human bnp
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid

Also Published As

Publication number Publication date
EP2098866A1 (en) 2009-09-09
US11105819B2 (en) 2021-08-31
US10641781B2 (en) 2020-05-05
JP2009204612A (ja) 2009-09-10
US9482677B2 (en) 2016-11-01
US20200158739A1 (en) 2020-05-21
EP2098866B1 (en) 2013-05-01
US20170003305A1 (en) 2017-01-05
US20090215182A1 (en) 2009-08-27
JP5734547B2 (ja) 2015-06-17

Similar Documents

Publication Publication Date Title
US11105819B2 (en) Method, composition and device for sampling natriuretic peptides in a biological fluid
EP1423705B1 (en) Conjunctive analysis of biological marker expression for diagnosing organ failure
KR101678703B1 (ko) 갈렉틴-３ 면역검정
US20100028921A1 (en) Risk stratification for acute coronary syndrome by means of fragments/partial peptides of provasopressin, especially copeptin or neurophysin ii
JP3411623B2 (ja) 心不全に対する検査方法
US8663941B2 (en) Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction
EP2265957A1 (en) Pro-endothelin-1 for the prediction of impaired peak oxygen consumption
EP1533613A1 (en) Soluble transferrin receptor
US20050014198A1 (en) Assays and kits for detecting and monitoring heart disease
AU2006214632A1 (en) Stabilized compositions containing natriuretic peptides
EP2322935B1 (en) Method for evaluating myocardial ischemic state using blood sample
Lippi et al. Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur
CN102854321B (zh) N末端b型脑钠肽前体化学发光免疫定量检测试剂盒及其制备方法
Nemcekova et al. Altered serum levels of neprilysin in heart failure patients with reduced ejection fraction.
Haq et al. Serum sialic acid and acute-phase proteins in hypertriglyceridaemic patients showing the Frederickson's type IIB phenotype
EP3740762B1 (en) Biomarker predicting coronary artery disease
Toda et al. Correlates of NT‐proBNP concentration in patients with essential hypertension in absence of congestive heart failure
CN101600967A (zh) 使用抗利尿激素原的片段/部分肽、特别是和肽素或后叶激素运载蛋白ⅱ对急性冠状动脉综合征进行危险性分级
Glatz et al. Fatty Acid Binding Protein as a Plasma Marker for the Early Assessment of Individuals with
Simpson Differential Detection of Skeletal Troponin I Isoforms in Serum of a Patient with Rhabdomyolysis: Markers of
HK1241021A1 (en) Nt-proanp and nt-probnp for the diagnosis of stroke
HK1229887A1 (en) Means and methods for assessing the risk of cardiac interventions based on gdf-15
HK1201327A1 (en) Nt-proanp and nt-probnp for the diagnosis of stroke
HK1201327B (en) Nt-proanp and nt-probnp for the diagnosis of stroke

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140226

FZDE Discontinued

Effective date: 20210831

FZDE Discontinued

Effective date: 20210831